Teladoc Health (NYSE:TDOC – Get Free Report) had its price objective cut by investment analysts at Wells Fargo & Company from $17.00 to $15.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm presently has an “equal weight” rating on the health services provider’s stock. Wells Fargo & Company‘s […]